Franck Tarendeau

Title: Franck Tarendeau: Innovator in Nucleic Acid Isolation and Viral Research

Introduction

Franck Tarendeau is a notable inventor based in Grenoble, France. He has made significant contributions to the fields of molecular biology and virology, holding a total of 3 patents. His work focuses on innovative methods for isolating nucleic acids and understanding viral mechanisms.

Latest Patents

One of Tarendeau's latest patents is a method for the specific isolation of nucleic acids of interest. This method involves a series of steps including bringing a liquid biological sample into contact with a saponin formulation, inducing osmotic shock to lyse untargeted elements, and selectively obtaining microorganisms or nucleic acids of interest. Another significant patent relates to soluble fragments of the Influenza virus RNA-dependent RNA polymerase subunit PB2. This invention includes methods for identifying compounds that bind to PB2 polypeptide fragments, which could lead to treatments for diseases caused by negative-sense single-stranded RNA viruses.

Career Highlights

Throughout his career, Franck Tarendeau has worked with prestigious organizations such as the European Molecular Biology Laboratory and bioMérieux, Inc. His experience in these institutions has allowed him to develop and refine his innovative techniques in molecular biology.

Collaborations

Tarendeau has collaborated with notable colleagues, including Darren James Hart and Stephen Cusack. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Franck Tarendeau's work exemplifies the intersection of innovation and practical application in the fields of molecular biology and virology. His patents not only advance scientific understanding but also hold potential for significant medical applications.